devices-with-shadow_high-heel

MolecuLight i:X TM

Wound Intelligence Device

The MolecuLight i:X allows clinicians to quickly, safely, and easily visualize bacteria and measure wounds at the point of care, so they have maximum insights for accurate treatment selection and accelerated healing.1,2,3

SN distributed by mark PRINT

Value-Proposition---8-Bubbles_22dec2017_

The MolecuLight i:X may help at every stage of wound care.

LEARN MORE

What Does MolecuLight i:X Do?

Visualize-Bacteria_white icon

Visualize Bacteria

MolecuLight i:X allows clinicians to focus on potentially harmful levels of bacteria with the guidance of fluorescence imaging.1,5,6

LEARN MORE

Measure Wound Size

MolecuLight i:X provides clinicians with automatic wound border detection and instant wound area measurements.

LEARN MORE

See Results

Study shows an 89% cost reduction and 9X faster wound healing with the use of the MolecuLight i:X Wound Intelligence Device.2

LEARN MORE

Making a Difference in Wound Care

54

%

More

Accurate

Swabbing

Compared to Standard Care 3

Find Out How

89

%

Overall

Reduction

in Costs

Compared to Standard Care 3

Find Out How

9X

Overall

Reduction

in Costs

Compared to Standard Care 3

Find Out How

How Does it Work?

Leveraging the principle of fluorescence, the MolecuLight i:X Wound Intelligence Device emits safe violet light which causes bacteria ≥ 104 CFU/g to fluoresce.4 The bacterial fluorescence signals detected by the device provide healthcare professionals with a visual indication of bacterial presence, load, and location within and around wounds in real-time to guide clinicians in their selection, application, and response monitoring of wound therapies.2,8,9

SN distributed by mark PRINT

Visit MolecuLight booth #W52 at EWMA 2018!

Clinicians from around the world will be talking
about their experiences with the MolecuLight i:X
and how the device has changed their clinical
practice and patient outcomes. Don’t miss our
exciting presentations and in-booth sessions!

View Presentation Schedule

References:

1. Wu YC, Smith M et al. Handheld fluorescence imaging device detects subclinical wound infection in an asymptomatic patient with chronic diabetic foot ulcer: a case report. Int Wound J. 2016 Aug;13(4):449-53.
2. DaCosta RS et al. Point-of-care autofluorescence imaging for real-time sampling and treatment guidance of bioburden in chronic wounds: first-in-human results. PLoS One. 2015 Mar 19;10(3).
3. Ottolino-Perry K et al. Improved detection of clinically relevant wound bacteria using autofluorescence image-guided sampling in diabetic foot ulcers. Int Wound J. 2017; doi: 10.1111/iwj.12717.
4. Rennie MY et al. (2017). Point-of-care fluorescence imaging predicts the presence of pathogenic bacteria in wounds: a clinical study. Journal of Wound Care; 2017 Aug 2; Vol 26 (8), 452-460. doi: 10.12968/jowc.2017.26.8.452.
5. Raizman R. Point-of-care fluorescence imaging device guides care and patient education in obese patients with surgical site infections. Presented at: CAWC 2016. Proceedings of the 22nd Annual Canadian Association of Wound Care Conference; 2016 Nov 3-6, Niagara Falls, ON.
6. Jeffery, S. Utility of point-of-care autofluorescence imaging device in successful closure of major limb amputations – a case study. Presented at: MHSRS 2016. Proceedings of the Military Health System Research Symposium; 2016 Aug 15-18; Kissimmee, FL.
7. MolecuLight Inc. Case Study 0051 Track Wound Size and Bacterial Presence with the MolecuLight i:X. 2016.
8. Wu YC et al. Autofluorescence imaging device for real-time detection and tracking of pathogenic bacteria in a mouse skin wound model: preclinical feasibility studies. J Biomed Opt. 2014 Aug;19(8).
9. Raizman R et al. Handheld real-time fluorescence imaging of bacteria guides treatment selection and timing of dressing changes in inpatients undergoing negative pressure wound therapy. Proceedings of the Innovations in Wound Healing Conference; 2016 Dec 8-11, Key Largo, FL.
10. Landis SL et al. Use of fluorescence imaging in visualizing bacteria in chronic ulcers and traumatic soft tissue damage. Proceedings of the Annual Meeting of the Society of Federal Health Professionals (AMSUS); 2016 Nov 29-Dec 2; National Harbor, MD.
11. Landis SJ. Mapping venous ulcers using bacterial autofluorescence (BAF) to identify subgroups at risk of infection post debridement. Proceedings of the Annual Canadian Association of Wound Care Conference; 2016 Nov 3-6, Niagara Falls, ON.
12. Hill R et al. Effect of bacterial fluorescence imaging on patient care and wound
management in a hospital setting: a pilot study. Proceedings of the Annual Symposium on Advanced Wound Care (SAWC); 2017 Apr 5-9; San Diego, CA.
13. Hill R et al. Real-time bacterial fluorescence imaging guides antimicrobial stewardship in patients with diverse wounds. Proceedings of the Annual Symposium on Advanced Wound Care (SAWC); 2017 Apr 5-9; San Diego, CA.
14. MolecuLight Inc. PN 1189 MolecuLight i:X User Manual. 2016.
15. Raizman R. Fluorescence imaging positively predicts bacterial presence and guides wound cleaning and patient education in a series of pilonidal sinus patients. Proceedings of the Annual Wounds UK Conference; 2016 Nov 14-16; Harrogate, UK.